SPL 3.06% 9.5¢ starpharma holdings limited

Patience, page-7

  1. 2,401 Posts.
    lightbulb Created with Sketch. 629
    I am by nature not that patient, but I will give Fairley until tomorrow week, the last day of the financial year, to release the Phase 2 data for Docetaxel, as she promised.

    Her likely failure to achieve that will precipitate a campaign for a EGM at which a vote of no confidence in the Chairman and CEO will be on the agenda.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.